ELEVAI Labs Inc ELAB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
0.69UNCH (UNCH)
Volume
9,753
Close
0.695UNCH (UNCH)
Volume
74,272
52 week range
0.61 - 4.24
Loading...
  • Open0.70
  • Day High0.7095
  • Day Low0.68
  • Prev Close0.69
  • 52 Week High4.24
  • 52 Week High Date11/27/23
  • 52 Week Low0.61
  • 52 Week Low Date02/13/24

Key Stats

  • Market Cap12.044M
  • Shares Out17.33M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-61.98

KEY STATS

  • Open0.70
  • Day High0.7095
  • Day Low0.68
  • Prev Close0.69
  • 52 Week High4.24
  • 52 Week High Date11/27/23
  • 52 Week Low0.61
  • 52 Week Low Date02/13/24
  • Market Cap12.044M
  • Shares Out17.33M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-61.98

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-3.17
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-3.348M
  • ROE (TTM)-
  • Revenue (TTM)1.153M
  • Gross Margin (TTM)66.47%
  • Net Margin (TTM)-329.28%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ELEVAI Labs Inc

 

Profile

MORE
Elevai Labs, Inc. is a physician-dispensed skincare company. The Company conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. It produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical...
Jordan Plews Ph.D.
President, Chief Executive Officer, Director
Graydon Bensler
Chief Financial Officer, Director
Address
120 Newport Center Drive, Ste 250
Newport Beach, CA
92660
United States